) The overall goals of this smoking cessation research are: 1) to understand the factors causing relapse to cigarettes, and 2) to design and evaluate treatments based on that understanding. In a 2 X 2 factorial design, where all subjects are receiving nicotine gum, the proposed research will test a series of hypotheses about the clinical efficacy, the cost, and the cost effectiveness of brief versus extended treatment, and of medical management alone versus medical management plus psychosocial support. In the brief treatment conditions, subjects will be treated for three months. In the extended treatment conditions, subjects will be treated for one year, which will include year long access to nicotine gum. This study has three interrelated foci: The first is to determine the relative efficacy of brief versus extended treatment in assisting smoking cessation; the second is to determine the relative efficacy of the two levels of psychosocial intervention (medical management alone vs. medical management plus psychosocial support) in assisting smoking cessation; and the third is to compare the cost and the cost effectiveness of these treatments. A total of 360 nicotine dependent individuals who are applying for smoking cessation treatment will be stratified by number of cigarettes smoked, past treatment failure using nicotine replacement therapy versus not, and on history of depression versus not, and randondy assigned from the stratified blocks to receive one of the four treatment conditions. A complete instrument battery will be done at baseline (Week 0); further assessments will be completed at brief treatment termination (Week 12), 6 months (Week 24), 9 months (Week 36), and one year (Week 52). Variables assessed are smoking behavior and biochemically verified smoking status, diagnosis, demographics and treatment history, state and trait measures of mood, support for quitting smoking, cigarette craving, and medication side effects. The cost effectiveness of the treatment conditions will be determined. If funded, this study will provide data about the efficacy and the cost effectiveness of treatments for smoking cessation based on rigorously designed clinical experiments. These data have implications for treatment providers and policy makers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA071378-03
Application #
2748868
Study Section
Special Emphasis Panel (SRC (13))
Program Officer
Backinger, Cathy L
Project Start
1996-09-15
Project End
2001-07-31
Budget Start
1998-09-23
Budget End
1999-07-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Hendricks, Peter S; Delucchi, Kevin L; Humfleet, Gary L et al. (2012) Alcohol and marijuana use in the context of tobacco dependence treatment: impact on outcome and mediation of effect. Nicotine Tob Res 14:942-51
Lawhon, Dawn; Humfleet, Gary L; Hall, Sharon M et al. (2009) Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol 28:465-72
Mooney, M E; Reus, V I; Gorecki, J et al. (2008) Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. Clin Pharmacol Ther 83:436-42
Humfleet, Gary L; Prochaska, Judith J; Mengis, Matilda et al. (2005) Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res 7:453-60
Hall, Sharon M; Lightwood, James M; Humfleet, Gary L et al. (2005) Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res 32:381-92
Acton, G Scott; Kunz, Jeffrey D; Wilson, Mark et al. (2005) The construct of internalization: conceptualization, measurement, and prediction of smoking treatment outcome. Psychol Med 35:395-408
Prochaska, Judith J; Rossi, Joseph S; Redding, Colleen A et al. (2004) Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend 76:143-51
Acton, G Scott (2003) Measurement of impulsivity in a hierarchical model of personality traits: implications for substance use. Subst Use Misuse 38:67-83
Jacob 3rd, Peyton; Hatsukami, Dorothy; Severson, Herbert et al. (2002) Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 11:1668-73
Xu, Bo; Kim, Seong-Tae; Lim, Dae-Sik et al. (2002) Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22:1049-59

Showing the most recent 10 out of 14 publications